Subject(s)
Neoplasms , Age Distribution , Humans , Incidence , Keratinocytes , Neoplasms/epidemiology , United Kingdom/epidemiologySubject(s)
COVID-19 , Skin Neoplasms , England/epidemiology , Humans , Incidence , Pandemics , SARS-CoV-2 , Skin Neoplasms/epidemiologyABSTRACT
Introduction: The most common cancers in the UK are keratinocyte cancers (KCs): the combined term for basal cell carcinomas (BCCs) and cutaneous squamous cell carcinomas (cSCCs). Registration of KC is challenging due to high numbers and multiplicity of tumours per person. Methods: We provide an updated report on the descriptive epidemiology of trends in KC incidence for the resident populations of UK countries (England, Northern Ireland, Scotland and Wales) using population-based cancer registry and pathology report data, 2013-18. Results: Substantial increases in cSCC incidence in England, Scotland and Northern Ireland can be detected for the period of 2013-18, and the incidence of cSCC also increased in Wales from 2016 to 2018. In contrast, however, the pattern of annual change in the incidence of BCC across the nations differs. In England, the incidence of BCC declined slightly from 2016 to 2018, however, the overall trend across 2013-18 is not statistically significant. In Scotland, the incidence of BCC shows some variability, declining in 2017 before increasing in 2018, and the overall trend across 2013-18 was also not statistically significant. In Northern Ireland, the incidence of BCC increased significantly over the study period, and in Wales, the incidence of BCC increased from 2016 to 2018. One in five people will develop non-melanoma skin cancers (NMSC) in their lifetime in England. This estimate is much higher than the lifetime risk of melanoma (1 in 36 males and 1 in 47 females born after 1960 in the UK), which further highlights the burden of the disease and importance of early prevention strategies. Conclusions: We highlight how common these tumours are by publishing the first ever lifetime incidence of NMSC. Additionally, the first time reporting of the age standardised incidence of KC in Wales further confirms the scale of the disease burden posed by these cancers in the UK. With approximately one in five people developing NMSC in their lifetime, optimisation of skin cancer prevention, management and research are essential.
Subject(s)
Erdheim-Chester Disease/genetics , Melanoma/genetics , Thyroid Cancer, Papillary/genetics , Turner Syndrome/genetics , Adult , Erdheim-Chester Disease/pathology , Female , Humans , Melanoma/pathology , Mutation , Neoplasms, Multiple Primary/genetics , Neoplasms, Multiple Primary/pathology , Proto-Oncogene Proteins B-raf/metabolism , Skin Neoplasms/pathology , Thyroid Cancer, Papillary/pathology , Thyroid Neoplasms/pathology , Turner Syndrome/pathologySubject(s)
Arthritis/genetics , Arthritis/pathology , Exanthema/etiology , Synovitis/genetics , Synovitis/pathology , Uveitis/genetics , Uveitis/pathology , Acute Disease , Adalimumab/administration & dosage , Adalimumab/therapeutic use , Anti-Inflammatory Agents/administration & dosage , Anti-Inflammatory Agents/therapeutic use , Arthritis/diagnosis , Arthritis/drug therapy , Diagnosis, Differential , Exanthema/diagnosis , Female , Humans , Infant , Nod2 Signaling Adaptor Protein/genetics , Sarcoidosis , Synovitis/drug therapy , Treatment Outcome , Uveitis/diagnosis , Uveitis/drug therapySubject(s)
Chilblains/etiology , Interleukin-1 Receptor-Associated Kinases/deficiency , Child , Female , HumansSubject(s)
Aminolevulinic Acid/analogs & derivatives , Photochemotherapy , Photosensitizing Agents/therapeutic use , Radiation Injuries/drug therapy , Scleroderma, Localized/drug therapy , Scleroderma, Localized/etiology , Aged , Aminolevulinic Acid/therapeutic use , Breast Neoplasms/radiotherapy , Carcinoma/radiotherapy , Female , Humans , Radiation Injuries/pathology , Radiotherapy/adverse effects , Scleroderma, Localized/pathologySubject(s)
Antipruritics/administration & dosage , Pruritus/therapy , Administration, Cutaneous , Adult , Aged , Complementary Therapies , Drug Eruptions/complications , Ectoparasitic Infestations/complications , Emotions , Endocrine System Diseases/complications , Forecasting , Hematologic Diseases/complications , Humans , Infections/complications , Iron Deficiencies , Iron Overload/complications , Liver Diseases/complications , Mental Disorders/complications , Neoplasms/complications , Nervous System Diseases/complications , Phototherapy/methods , Primary Health Care , Pruritus/diagnosis , Pruritus/etiology , Uremia/complicationsABSTRACT
Perimenstrual exacerbations of dermatoses are commonly recognized, yet our knowledge of the underlying pathophysiological mechanisms remains imperfect. Research into the effects of oestrogen on the skin has provided evidence to suggest that oestrogen is associated with increases in skin thickness and dermal water content, improved barrier function, and enhanced wound healing. Research into the effects of progesterone suggests that the presence of various dermatoses correlates with peak levels of progesterone. Dermatoses that are exacerbated perimenstrually include acne, psoriasis, atopic eczema and irritant dermatitis, and possibly also erythema multiforme. Exacerbations occur at the peak levels of progesterone in the menstrual cycle. Underlying mechanisms include reduced immune and barrier functions as a result of cyclical fluctuations in oestrogen and/or progesterone. Autoimmune progesterone and oestrogen dermatitis are the best-characterized examples of perimenstrual cutaneous reactions to hormones produced during the menstrual cycle. In this review, we describe the current understanding of the menstrual cycle, and its effect on the skin and cutaneous disorders.
Subject(s)
Dermatitis/immunology , Menstrual Cycle/physiology , Estrogens/physiology , Female , Humans , Progesterone/physiologyABSTRACT
The increasing problem of obesity in childhood is recognized as both a short-term and long-term serious public-health concern. Excess body weight may contribute to psychological morbidity; cancers; metabolic, cardiovascular and musculoskeletal disorders; and dermatological conditions. There is increasing recognition of the role of genetic factors in the aetiology of obesity. Although in the vast majority of cases these influences are polygenic, some obese children suffer from monogenic disorders, which may present with obesity alone. However, more often than not, they generally display other syndromic features. Some of these syndromes have a clear cutaneous phenotype, and these conditions will be the focus of this review.